New recommendation with the purpose of strengthening clinical research in Denmark

​A working committee has formulated recommendations on how Denmark can enhance global competition and remain an attractive collaborator in clinical research.

The Danish minister of business, Morten Bødskov, paid a visit to the Phase 1 Unit to gain insights into our work and discuss the new recommendations. 

The primary object of these new recommendations is to further elevate Denmark’s global standing within clinical research, with the ultimate advantage of providing patients with access to the latest treatments and technologies. 

Within the recommendations, the working committee has identified three central areas of intervention. Among these is the optimization of administrative processes for initiation and implementation of clinical research, as well as the exploration of the numerous opportunities presented by emerging technologies in data management. 

Read the Danish article here

Responsible editor